North America Newborn Screening Market to 2032
Overview
The North America Newborn Screening Market is expected to reach a 2,068.67 USD Billion by 2032 and is projected to grow at a CAGR of 13.80% from 2025 to 2032.
Revenue, 2024 (USD Billion)
925.63
Forecast, 2032 (USD Billion)
2,068.67
CAGR, 2024 - 2032
13.80%
Report Coverage
North America
North America Newborn Screening Market 2018-2032 USD Billion
North America Newborn Screening Market , Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 925.63 USD Billion
- Projected Market Size (2032): 2,068.67 USD Billion
- CAGR (2025-2032): 13.80%
Key Findings of North America Newborn Screening Market
- The North America Newborn Screening Market was valued at 925.63 USD Billion in 2024.
- The North America Newborn Screening Market is likely to grow at a CAGR of 13.80% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Hospital in End User Segment accounted for the largest share of the market with a revenue of 665.00 USD Billion
- The fastest growing segment Tandem Mass Spectrometry in Technology Segment grew Fastest with a CAGR of 15.67% during the forecast period from 2024 to 2032.
North America Newborn Screening Market Scope
North America Newborn Screening Market Segmentation & Scope
End User
- Clinics
- Pediatric Clinics
- Hospital
Disease Type
- Others
- Maple Syrup Urine Disease
- Phenylketonuria (PKU)
- Cystic Fibrosis (CF)
- Sickle Cell Disease
- Newborn Hearing Loss
- Critical Congenital Heart Diseases
Technology
- DNA-Based Assays
- Electrophoresis
- Immunoassays and Enzymatic Assays
- Pulse Oximetry Screening Technology
- Hearing Screen Technology
- Tandem Mass Spectrometry
Product Type
- Reagents and Assay Kits
- Instruments
Test Type
- Critical Congenital Heart Diseases (CCHD) Test
- Hearing Screen Test
- Dried Blood Spot Test
North America Newborn Screening Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 925.63 USD Billion |
| Market Value in 2032 | 2,068.67 USD Billion |
| CAGR (2025-2032) | 13.80% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Disease Type,Technology,Product Type,Test Type |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 925.63 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 802.32 USD Billion in 2024.
Segments and Scope
-
North America Newborn Screening Market to 2032, By End User
- Hospital is the largest segment in North America Newborn Screening Market to 2032 with a revenue of 665.00 USD Billion in the year 2024.
- Hospital is the Fastest growing segment in North America Newborn Screening Market to 2032 with a Growth rate of 14.13 % in forecast period 2025-2032.
-
North America Newborn Screening Market to 2032, By Disease Type
- Critical Congenital Heart Diseases is the largest segment in North America Newborn Screening Market to 2032 with a revenue of 605.35 USD Billion in the year 2024.
- Critical Congenital Heart Diseases is the Fastest growing segment in North America Newborn Screening Market to 2032 with a Growth rate of 14.25 % in forecast period 2025-2032.
-
North America Newborn Screening Market to 2032, By Technology
- Tandem Mass Spectrometry is the largest segment in North America Newborn Screening Market to 2032 with a revenue of 262.00 USD Billion in the year 2024.
- Tandem Mass Spectrometry is the Fastest growing segment in North America Newborn Screening Market to 2032 with a Growth rate of 15.67 % in forecast period 2025-2032.
-
North America Newborn Screening Market to 2032, By Product Type
- Instruments is the largest segment in North America Newborn Screening Market to 2032 with a revenue of 629.88 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in North America Newborn Screening Market to 2032 with a Growth rate of 14.17 % in forecast period 2025-2032.
-
North America Newborn Screening Market to 2032, By Test Type
- Dried Blood Spot Test is the largest segment in North America Newborn Screening Market to 2032 with a revenue of 393.19 USD Billion in the year 2024.
- Hearing Screen Test is the Fastest growing segment in North America Newborn Screening Market to 2032 with a Growth rate of 13.42 % in forecast period 2025-2032.
North America Newborn Screening Market Company Share Analysis
North America Newborn Screening Market Geographical Sales Distribution, 2018-2032 USD Billion
North America Newborn Screening Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Newborn Screening Market is segmented based on Segmentation End User,Disease Type,Technology,Product Type,Test Type.
North America Newborn Screening Market was valued at USD 925.63(Revenue in USD Billion) in 2022.
North America Newborn Screening Market is projected to grow at a CAGR of 13.80% during the forecast period of 2024 to 2032.
The Hospital segment is expected to dominate the North America Newborn Screening Market , holding a largest market share of 665.00 USD Billion in 2024
North America Newborn Screening Market Scope
North America Newborn Screening Market Segmentation & Scope
End User
- Clinics
- Pediatric Clinics
- Hospital
Disease Type
- Others
- Maple Syrup Urine Disease
- Phenylketonuria (PKU)
- Cystic Fibrosis (CF)
- Sickle Cell Disease
- Newborn Hearing Loss
- Critical Congenital Heart Diseases
Technology
- DNA-Based Assays
- Electrophoresis
- Immunoassays and Enzymatic Assays
- Pulse Oximetry Screening Technology
- Hearing Screen Technology
- Tandem Mass Spectrometry
Product Type
- Reagents and Assay Kits
- Instruments
Test Type
- Critical Congenital Heart Diseases (CCHD) Test
- Hearing Screen Test
- Dried Blood Spot Test
Frequently Asked Questions
The North America Newborn Screening Market is segmented based on Segmentation End User,Disease Type,Technology,Product Type,Test Type.
North America Newborn Screening Market was valued at USD 925.63(Revenue in USD Billion) in 2022.
North America Newborn Screening Market is projected to grow at a CAGR of 13.80% during the forecast period of 2024 to 2032.
The estimated market value of the North America Newborn Screening Market for final year is USD 2,068.67 (USD Billion).
North America Newborn Screening Market Company Profiling
Frequently Asked Questions
The North America Newborn Screening Market is segmented based on Segmentation End User,Disease Type,Technology,Product Type,Test Type.
North America Newborn Screening Market was valued at USD 925.63(Revenue in USD Billion) in 2022.
North America Newborn Screening Market is projected to grow at a CAGR of 13.80% during the forecast period of 2024 to 2032.
The estimated market value of the North America Newborn Screening Market for final year is USD 2,068.67 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.